igf-1 lr3 QK041 IGF-1 LR3 1mg | Research
Description
doi: 10.1016/0304-3835(91)90104-p
Injectable formulations require prescriber oversight
If a peptide forms a cloudy suspension or visible precipitate when mixed with reconstitution solution, consult the product documentation for solvent recommendations
doi: 10.1016/j.jprot.2021.104464 88 JiangXStockwellBRConradM
